Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

B. M. Mercer, M. Miodovnik, G. R. Thurnau, R. L. Goldenberg, A. F. Das, R. D. Ramsey, Y. A. Rabello, P. J. Meis, A. H. Moawad, J. D. Iams, J. P. Van Dorsten, R. H. Paul, S. F. Bottoms, G. Merenstein, E. A. Thom, J. M. Roberts and D. McNellis
University of Tennessee, Memphis 38103, USA. bmercer@utmem1.utmem.edu

CONTEXT: Intrauterine infection is thought to be one cause of preterm premature rupture of the membranes (PPROM). Antibiotic therapy has been shown to prolong pregnancy, but the effect on infant morbidity has been inconsistent. OBJECTIVE: To determine if antibiotic treatment during expectant management of PPROM will reduce infant morbidity. DESIGN: Randomized, double-blind, placebo-controlled trial. SETTING: University hospitals of the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. PATIENTS: A total of 614 of 804 eligible gravidas with PPROM between 24 weeks' and 0 days' and 32 weeks' and 0 days' gestation who were considered candidates for pregnancy prolongation and had not received corticosteroids for fetal maturation or antibiotic treatment within 1 week of randomization. INTERVENTIONS: Intravenous ampicillin (2-g dose every 6 hours) and erythromycin (250-mg dose every 6 hours) for 48 hours followed by oral amoxicillin (250-mg dose every 8 hours) and erythromycin base (333-mg dose every 8 hours) for 5 days vs a matching placebo regimen. Group B streptococcus (GBS) carriers were identified and treated. Tocolysis and corticosteroids were prohibited after randomization. MAIN OUTCOME MEASURES: The composite primary outcome included pregnancies complicated by at least one of the following: fetal or infant death, respiratory distress, severe intraventricular hemorrhage, stage 2 or 3 necrotizing enterocolitis, or sepsis within 72 hours of birth. These perinatal morbidities were also evaluated individually and pregnancy prolongation was assessed. RESULTS: In the total study population, the primary outcome (44.1 % vs 52.9%; P=.04), respiratory distress (40.5% vs 48.7%; P=.04), and necrotizing enterocolitis (2.3% vs 5.8%; P=.03) were less frequent with antibiotics. In the GBS-negative cohort, the antibiotic group had less frequent primary outcome (44.5% vs 54.5%; P=.03), respiratory distress (40.8% vs 50.6%; P=.03), overall sepsis (8.4% vs 15.6%; P=.01), pneumonia (2.9% vs 7.0%; P=.04), and other morbidities. Among GBS-negative women, significant pregnancy prolongation was seen with antibiotics (P<.001). CONCLUSIONS: We recommend that women with expectantly managed PPROM remote from term receive antibiotics to reduce infant morbidity.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Changing Patterns in Neonatal Escherichia coli Sepsis and Ampicillin Resistance in the Era of Intrapartum Antibiotic Prophylaxis
Bizzarro et al.
Pediatrics 2008;121:689-696.
ABSTRACT | FULL TEXT  

Drug therapy during labor and delivery, part 1.
Briggs and Wan
Am J Health Syst Pharm 2006;63:1038-1047.
ABSTRACT | FULL TEXT  

Antibiotic Use in Pregnancy and Lactation: What Is and Is Not Known About Teratogenic and Toxic Risks.
Nahum et al.
Obstet Gynecol 2006;107:1120-1138.
ABSTRACT | FULL TEXT  

Proinflammatory Cytokines Found in Amniotic Fluid Induce Collagen Remodeling, Apoptosis, and Biophysical Weakening of Cultured Human Fetal Membranes
Kumar et al.
Biol. Reprod. 2006;74:29-34.
ABSTRACT | FULL TEXT  

Chorioamnionitis associated with Crohn's disease and azathioprine treatment: a case report
Helpman et al.
J Med Microbiol 2005;54:803-804.
ABSTRACT | FULL TEXT  

Executive Summary of the Workshop on the Border of Viability
Higgins et al.
Pediatrics 2005;115:1392-1396.
ABSTRACT | FULL TEXT  

Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence
Bhutta et al.
Pediatrics 2005;115:519-617.
ABSTRACT | FULL TEXT  

Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme
Cheng et al.
Antimicrob. Agents Chemother. 2005;49:111-117.
ABSTRACT | FULL TEXT  

Antibiotics for Preterm Rupture of the Membranes: A Systematic Review
Kenyon et al.
Obstet Gynecol 2004;104:1051-1057.
ABSTRACT | FULL TEXT  

Perinatal Infections Due to Group B Streptococci
Gibbs et al.
Obstet Gynecol 2004;104:1062-1076.
ABSTRACT | FULL TEXT  

Endotoxin Inhibits Intestinal Epithelial Restitution through Activation of Rho-GTPase and Increased Focal Adhesions
Cetin et al.
J. Biol. Chem. 2004;279:24592-24600.
ABSTRACT | FULL TEXT  

Prenatal screening for group B streptococcal infection: gaps in the evidence
Gilbert
Int J Epidemiol 2004;33:2-8.
FULL TEXT  

Preterm Premature Rupture of the Membranes
Mercer
Obstet Gynecol 2003;101:178-193.
ABSTRACT | FULL TEXT  

Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
Stoll et al.
NEJM 2002;347:240-247.
ABSTRACT | FULL TEXT  

Infection-related Preterm Birth: A Review of the Evidence
Guinn and Gibbs
NeoReviews 2002;3:e86-96.
FULL TEXT  

Preventing Recurrent Second Trimester Group B Streptococcus Chorioamnionitis by Intermittent Prophylactic Ampicillin
Marinoff and Chinn
Obstet Gynecol 2001;98:918-919.
ABSTRACT | FULL TEXT  

Improving Survival of Vulnerable Infants Increases Neonatal Intensive Care Unit Nosocomial Infection Rate
Zafar et al.
Arch Pediatr Adolesc Med 2001;155:1098-1104.
ABSTRACT | FULL TEXT  

Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection
Herting et al.
Pediatrics 2000;106:957-964.
ABSTRACT | FULL TEXT  

Expanded-Spectrum Antibiotics With Preterm Premature Rupture of Membranes
EDWARDS et al.
Obstet Gynecol 2000;96:60-64.
ABSTRACT | FULL TEXT  

Intrauterine Infection and Preterm Delivery
Goldenberg et al.
NEJM 2000;342:1500-1507.
FULL TEXT  

Prevention of Premature Birth: Do Pediatricians Have a Role?
Hall
Pediatrics 2000;105:1137-1140.
ABSTRACT | FULL TEXT  

Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study
Schuchat et al.
Pediatrics 2000;105:21-26.
ABSTRACT | FULL TEXT  

Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review
Benitz et al.
Pediatrics 1999;103:78e-78.
ABSTRACT | FULL TEXT  

Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics
Mohle-Boetani et al.
Pediatrics 1999;103:703-710.
ABSTRACT | FULL TEXT  

Prevention of Premature Birth
Goldenberg and Rouse
NEJM 1998;339:313-320.
FULL TEXT  

Antibiotic Therapy for Premature Rupture of Membranes to Prevent Respiratory Distress Syndrome
Cimolai et al.
JAMA 1998;279:748-749.
FULL TEXT  

Premature Rupture of Membranes, Antibiotics, and Amnionitis
Cooperstock et al.
JAMA 1998;279:22-22.
FULL TEXT  

Antibiotics for Preterm Membrane Rupture
JWatch Women's Health 1997;1997:2-2.
FULL TEXT  

ANTIBIOTICS BENEFIT NEONATE AFTER PREMATURE MEMBRANE RUPTURE
JWatch General 1997;1997:2-2.
FULL TEXT